Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-26 @ 1:41 AM
Study NCT ID:
NCT03400033
Status:
COMPLETED
Last Update Posted:
2021-07-12
First Post:
2018-01-08
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2020-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-06-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-08
First Submit QC Date:
None
Study First Post Date:
2018-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-18
Results First Submit QC Date:
None
Results First Post Date:
2021-07-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-18
Last Update Post Date:
2021-07-12
Last Update Post Date Type:
ACTUAL